Cargando…
Host-Directed Antimicrobial Drugs with Broad-Spectrum Efficacy against Intracellular Bacterial Pathogens
We sought a new approach to treating infections by intracellular bacteria, namely, by altering host cell functions that support their growth. We screened a library of 640 Food and Drug Administration (FDA)-approved compounds for agents that render THP-1 cells resistant to infection by four intracell...
Autores principales: | Czyż, Daniel M., Potluri, Lakshmi-Prasad, Jain-Gupta, Neeta, Riley, Sean P., Martinez, Juan J., Steck, Theodore L., Crosson, Sean, Shuman, Howard A., Gabay, Joëlle E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Microbiology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128363/ https://www.ncbi.nlm.nih.gov/pubmed/25073644 http://dx.doi.org/10.1128/mBio.01534-14 |
Ejemplares similares
-
A dual-targeting approach to inhibit Brucella abortus replication in human cells
por: Czyż, Daniel M., et al.
Publicado: (2016) -
Chemical Genetics Reveals Bacterial and Host Cell Functions Critical for Type IV Effector Translocation by Legionella pneumophila
por: Charpentier, Xavier, et al.
Publicado: (2009) -
Light as a Broad-Spectrum Antimicrobial
por: Gwynne, Peter J., et al.
Publicado: (2018) -
Tilorone, a Broad-Spectrum Antiviral for Emerging Viruses
por: Ekins, Sean, et al.
Publicado: (2020) -
Advantage of a Narrow Spectrum Host Defense (Antimicrobial) Peptide Over a Broad Spectrum Analog in Preclinical Drug Development
por: Ostorhazi, Eszter, et al.
Publicado: (2018)